Hematology/Oncology News

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more.

PROVIDENCE, Rhode Island — Physicians and other health care professionals can utilize social media to support diversity, equity and inclusion in cancer care, according to a presenter at the COSMO Meeting.

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children Act went into effect in 2020, a study showed.

The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.

Patritumab deruxtecan improved PFS compared with chemotherapy among certain patients with advanced non-small cell lung cancer, according to the agent’s manufacturer.

Most physicians and residents report feelings of burnout, while stigma about receiving mental health care remains prevalent, according to a new report from The Physicians Foundation.

Mammography and digital breast tomosynthesis lead to very similar outcomes, so shared-decision making is important for breast cancer screening, according to an expert.

Ovarian cancer care costs are considerable, varying by care phase, age and geographic region, with the highest costs observed at initiation of and end-of-life care, researchers reported in the American Journal of Obstetrics and Gynecology.